癌症
糖
癌症治疗
癌细胞
癌症研究
医学
化学
生物化学
内科学
作者
Rajan Swami,Shubha Vij,Shubham Sharma
出处
期刊:Nanomedicine
日期:2024-02-01
卷期号:19 (5): 431-453
标识
DOI:10.2217/nnm-2023-0276
摘要
Cancer cells need as much as 40-times more sugar than their normal cell counterparts. This sugar demand is attained by the excessive expression of inimitable transporters on the surface of cancer cells, driven by their voracious appetite for carbohydrates. Nanotechnological advances drive research utilizing ligand-directed therapeutics and diverse carbohydrate analogs. The precise delivery of these therapeutic cargos not only mitigates toxicity associated with chemotherapy but also reduces the grim toll of mortality and morbidity among patients. This in-depth review explores the potential of these ligands in advanced cancer treatment using nanoparticles. It offers a broader perspective beyond the usual ways we deliver drugs, potentially changing the way we fight cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI